Amneal Pharmaceuticals (AMRX) Preferred Dividend Payments (2018 - 2022)
Amneal Pharmaceuticals' (AMRX) quarterly Preferred Dividend Payments came in at $438000.0 in Q1 2022, down 96.26% quarter-over-quarter from $11.7 million in Q3 2018.
Amneal Pharmaceuticals (AMRX) Preferred Dividend Payments (2018 - 2022) Analysis & Trends
Amneal Pharmaceuticals' Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $438000.0 for Q1 2022.
- On a quarterly basis, Preferred Dividend Payments changed N/A year-over-year to $438000.0 in Q1 2022; TTM through Dec 2022 was $438000.0, a N/A change from a year earlier, with the FY2022 full-year figure at $438000.0, changed N/A from the prior year.
- Preferred Dividend Payments retreated to $438000.0 in Q1 2022 per AMRX's latest filing, from $11.7 million in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $11.7 million in Q3 2018 and bottomed at $438000.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Amneal Pharmaceuticals | 5.68 Bn | 5.67 Bn | 320.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 438,000.00 |
| Sep 30, 2018 | 11.71 Mn |